What is the treatment for otitis media?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Acute Otitis Media

Amoxicillin at 80-90 mg/kg/day divided into 2 doses is the first-line antibiotic for acute otitis media in children, while watchful waiting without antibiotics is appropriate for children ≥2 years with mild-to-moderate symptoms. 1, 2

Initial Management Decision

The approach depends on age, symptom severity, and clinical presentation:

  • Immediate antibiotics are indicated for: 1, 2

    • All children <6 months of age
    • Children <2 years with confirmed AOM
    • Any child with severe symptoms (moderate-to-severe otalgia, otalgia >48 hours, or temperature ≥39°C/102.2°F)
    • Concurrent purulent conjunctivitis
  • Watchful waiting (observation without antibiotics) is appropriate for: 1, 2

    • Children ≥2 years with mild-to-moderate symptoms
    • Requires reliable follow-up within 48-72 hours
    • Parents must have access to antibiotics if symptoms worsen
  • Pain management must be addressed immediately in ALL patients, regardless of antibiotic decision, especially during the first 24 hours. 1, 2 Topical analgesics may provide relief within 10-30 minutes, and NSAIDs are significantly more effective than placebo. 1

First-Line Antibiotic Selection

Amoxicillin 80-90 mg/kg/day in 2 divided doses is the standard first-line therapy due to its effectiveness against common pathogens (S. pneumoniae, H. influenzae, M. catarrhalis), excellent safety profile, low cost, acceptable taste, and narrow microbiologic spectrum. 1, 2

Second-Line Antibiotic Selection

Switch to amoxicillin-clavulanate (90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day of clavulanate in 2 divided doses) for: 1, 2

  • Amoxicillin use within the previous 30 days
  • Concurrent purulent conjunctivitis
  • Coverage needed for beta-lactamase-producing organisms (H. influenzae, M. catarrhalis)

Penicillin Allergy Alternatives

For patients with penicillin allergy, use: 1

  • Cefdinir 14 mg/kg/day in 1-2 doses
  • Cefuroxime 30 mg/kg/day in 2 divided doses
  • Cefpodoxime 10 mg/kg/day in 2 divided doses
  • Ceftriaxone 50 mg IM or IV daily for 1-3 days

Cross-reactivity between penicillins and second/third-generation cephalosporins is lower than historically reported, making these cephalosporins generally safe for non-severe penicillin allergies. 1

Treatment Duration

  • Children <2 years and those with severe symptoms: 10-day course 1, 2
  • Children 2-5 years with mild-to-moderate AOM: 7-day course (equally effective to 10 days) 1, 2
  • Children ≥6 years with mild-to-moderate symptoms: 5-7 day course 1

Management of Treatment Failure

If symptoms worsen or fail to improve within 48-72 hours: 1, 2

  1. Reassess to confirm AOM diagnosis
  2. Switch to amoxicillin-clavulanate if initially on amoxicillin
  3. If already on amoxicillin-clavulanate, use ceftriaxone 50 mg/kg IM daily for 1-3 days (3-day course superior to 1-day regimen) 1
  4. Consider tympanocentesis with culture and susceptibility testing for multiple treatment failures 1, 2

Alternative Regimen: Azithromycin

While not first-line per guidelines, azithromycin is FDA-approved for pediatric acute otitis media: 3

  • 30 mg/kg as single dose (1-day regimen)
  • 10 mg/kg once daily for 3 days (3-day regimen)
  • 10 mg/kg Day 1, then 5 mg/kg Days 2-5 (5-day regimen)

Clinical success rates at Day 11-14 ranged from 83-89% across trials, comparable to amoxicillin-clavulanate. 3 However, azithromycin is not recommended as first-line by AAP guidelines due to increasing macrolide resistance. 1

Post-Treatment Follow-Up

  • 60-70% of children have middle ear effusion at 2 weeks post-treatment, decreasing to 40% at 1 month and 10-25% at 3 months. 1
  • Middle ear effusion without acute symptoms after AOM resolution is otitis media with effusion (OME), which requires monitoring but NOT antibiotics. 1, 2

Recurrent AOM Management

For recurrent AOM (≥3 episodes in 6 months or ≥4 episodes in 12 months): 1, 2

  • Consider tympanostomy tube placement (failure rates: 21% for tubes alone, 16% for tubes with adenoidectomy)
  • Antimicrobial prophylaxis is an alternative but less preferred option

Prevention Strategies

Risk reduction includes: 1, 2

  • Breastfeeding
  • Avoiding tobacco smoke exposure
  • Limiting pacifier use in older infants/children
  • Pneumococcal vaccination

Critical Pitfalls to Avoid

  • Do NOT use topical antibiotics for AOM - these are contraindicated and only indicated for otitis externa or tube otorrhea. 1
  • Do NOT use ototoxic topical preparations when tympanic membrane integrity is uncertain. 1
  • Antibiotics do NOT eliminate the risk of complications like acute mastoiditis - 33-81% of mastoiditis patients had received prior antibiotics. 1

References

Guideline

Treatment of Acute Otitis Media

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acute Otitis Media Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.